Influenza-associated pneumonia hospitalizations in Uganda, 2013-2016.
Journal
PloS one
ISSN: 1932-6203
Titre abrégé: PLoS One
Pays: United States
ID NLM: 101285081
Informations de publication
Date de publication:
2019
2019
Historique:
received:
07
02
2019
accepted:
13
06
2019
entrez:
16
7
2019
pubmed:
16
7
2019
medline:
3
3
2020
Statut:
epublish
Résumé
Influenza is an important contributor to acute respiratory illness, including pneumonia, and results in substantial morbidity and mortality globally. Understanding the local burden of influenza-associated severe disease can inform decisions on allocation of resources toward influenza control programs. Currently, there is no national influenza vaccination program in Uganda. In this study, we used data on pneumonia hospitalizations that were collected and reported through the Health Management Information System (HMIS) of the Ministry of Health, Uganda, and the laboratory-confirmed influenza positivity data from severe acute respiratory illness (SARI) surveillance in three districts (Wakiso, Mbarara, and Tororo) to estimate the age-specific incidence of influenza-associated pneumonia hospitalizations from January 2013 through December 2016. The overall estimated mean annual rate of pneumonia hospitalizations in the three districts was 371 (95% confidence interval [CI] 323-434) per 100,000 persons, and was highest among children aged <5 years (1,524 [95% CI 1,286-1,849]) compared to persons aged ≥5 years (123 [95% CI 105-144]) per 100,000 persons. The estimated mean annual rate of influenza-associated pneumonia hospitalization was 34 (95% CI 23-48) per 100,000 persons (116 [95% CI 78-165] and 16 [95% CI 6-28] per 100,000 persons among children aged <5 years and those ≥5 years, respectively). Among children aged <5 years, the rate of hospitalized influenza-associated pneumonia was highest among those who were <2 years old (178 [95% CI 109-265] per 100,000 persons). Over the period of analysis, the estimated mean annual number of hospitalized influenza-associated pneumonia cases in the three districts ranged between 672 and 1,436, of which over 70% represent children aged <5 years. The burden of influenza-associated pneumonia hospitalizations was substantial in Uganda, and was highest among young children aged <5 years. Influenza vaccination may be considered, especially for very young children.
Sections du résumé
BACKGROUND
Influenza is an important contributor to acute respiratory illness, including pneumonia, and results in substantial morbidity and mortality globally. Understanding the local burden of influenza-associated severe disease can inform decisions on allocation of resources toward influenza control programs. Currently, there is no national influenza vaccination program in Uganda.
METHODS
In this study, we used data on pneumonia hospitalizations that were collected and reported through the Health Management Information System (HMIS) of the Ministry of Health, Uganda, and the laboratory-confirmed influenza positivity data from severe acute respiratory illness (SARI) surveillance in three districts (Wakiso, Mbarara, and Tororo) to estimate the age-specific incidence of influenza-associated pneumonia hospitalizations from January 2013 through December 2016.
RESULTS
The overall estimated mean annual rate of pneumonia hospitalizations in the three districts was 371 (95% confidence interval [CI] 323-434) per 100,000 persons, and was highest among children aged <5 years (1,524 [95% CI 1,286-1,849]) compared to persons aged ≥5 years (123 [95% CI 105-144]) per 100,000 persons. The estimated mean annual rate of influenza-associated pneumonia hospitalization was 34 (95% CI 23-48) per 100,000 persons (116 [95% CI 78-165] and 16 [95% CI 6-28] per 100,000 persons among children aged <5 years and those ≥5 years, respectively). Among children aged <5 years, the rate of hospitalized influenza-associated pneumonia was highest among those who were <2 years old (178 [95% CI 109-265] per 100,000 persons). Over the period of analysis, the estimated mean annual number of hospitalized influenza-associated pneumonia cases in the three districts ranged between 672 and 1,436, of which over 70% represent children aged <5 years.
CONCLUSIONS
The burden of influenza-associated pneumonia hospitalizations was substantial in Uganda, and was highest among young children aged <5 years. Influenza vaccination may be considered, especially for very young children.
Identifiants
pubmed: 31306466
doi: 10.1371/journal.pone.0219012
pii: PONE-D-19-03696
pmc: PMC6629074
doi:
Types de publication
Journal Article
Research Support, U.S. Gov't, P.H.S.
Langues
eng
Sous-ensembles de citation
IM
Pagination
e0219012Déclaration de conflit d'intérêts
The authors have declared that no competing interests exist.
Références
Influenza Other Respir Viruses. 2018 Jan;12(1):30-37
pubmed: 29243402
J Infect Dis. 2012 Dec 15;206 Suppl 1:S87-93
pubmed: 23169978
Afr J Lab Med. 2013 Jun 24;2(1):65
pubmed: 29043164
Lancet. 2018 Mar 31;391(10127):1285-1300
pubmed: 29248255
PLoS One. 2014 Jun 23;9(6):e98615
pubmed: 24955962
Influenza Other Respir Viruses. 2018 Jan;12(1):46-53
pubmed: 29243406
Influenza Other Respir Viruses. 2012 Jan;6(1):11-24
pubmed: 21668669
Influenza Other Respir Viruses. 2019 Mar;13(2):138-147
pubmed: 30596225
Epidemiol Infect. 2011 Oct;139(10):1560-9
pubmed: 21108872
PLoS Med. 2016 Mar 24;13(3):e1001977
pubmed: 27011229
Bull World Health Organ. 2008 May;86(5):408-16
pubmed: 18545744
Influenza Other Respir Viruses. 2016 Jul;10(4):333-9
pubmed: 27219455
Influenza Other Respir Viruses. 2018 Jul;12(4):446-456
pubmed: 29573157
BMC Infect Dis. 2016 Dec 13;16(1):757
pubmed: 27964716
Influenza Other Respir Viruses. 2018 Jan;12(1):38-45
pubmed: 29197152
J Pediatr. 2010 Nov;157(5):808-14
pubmed: 20580018
MMWR Morb Mortal Wkly Rep. 2015 Jun 5;64(21):583-90
pubmed: 26042650
Lancet. 2011 Dec 3;378(9807):1917-30
pubmed: 22078723
Clin Infect Dis. 2012 May;54(10):1427-36
pubmed: 22495079
Lancet Infect Dis. 2011 Mar;11(3):223-35
pubmed: 21371656
MMWR Recomm Rep. 2010 Aug 6;59(RR-8):1-62
pubmed: 20689501
Curr Opin Infect Dis. 2010 Oct;23(5):415-20
pubmed: 20644472
Epidemics. 2018 Sep;24:43-48
pubmed: 29576517
HIV Med. 2011 Oct;12(9):553-61
pubmed: 21535347
PLoS Med. 2006 Apr;3(4):e89
pubmed: 16509764
PLoS One. 2015 Sep 23;10(9):e0138708
pubmed: 26398196
Open Forum Infect Dis. 2017 Feb 10;4(1):ofw262
pubmed: 28480255